Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 30/100

Failure Rate

5.9%

1 terminated/withdrawn out of 17 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

41%

7 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

8 recruiting2 with results

Enrollment Performance

Analytics

Phase 2
7(41.2%)
Phase 3
6(35.3%)
N/A
3(17.6%)
Phase 4
1(5.9%)
17Total
Phase 2(7)
Phase 3(6)
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (17)

Showing 17 of 17 trials
NCT05137119Phase 4Recruiting

Staphylococcus Aureus Network Adaptive Platform Trial

Role: collaborator

NCT06289985Not ApplicableRecruiting

StrokeNet Thrombectomy Endovascular Platform

Role: collaborator

NCT04606264Phase 3Completed

Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data

Role: collaborator

NCT05948579Phase 2Not Yet Recruiting

Department of Defense PTSD Adaptive Platform Trial - Intervention B - Vilazodone

Role: collaborator

NCT05948553Phase 2Recruiting

Department of Defense PTSD Adaptive Platform Trial - Intervention A - Fluoxetine

Role: collaborator

NCT05948540Phase 2Recruiting

Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant

Role: collaborator

NCT05422612Phase 2Recruiting

Department of Defense PTSD Adaptive Platform Trial - Master Protocol

Role: collaborator

NCT06816433Phase 2Not Yet Recruiting

Department of Defense PTSD Adaptive Platform Trial - Intervention D - SLS-002

Role: collaborator

NCT05018221Phase 3Recruiting

Better Evidence and Translation for Calciphylaxis

Role: collaborator

NCT04577859Not ApplicableActive Not Recruiting

Esophageal Protection Study: A Multicenter Study

Role: collaborator

NCT06526533Phase 3Not Yet Recruiting

RECOMMEND Platform Trial

Role: collaborator

NCT06352632Phase 3Recruiting

ACT-GLOBAL Adaptive Platform Trial for Stroke

Role: collaborator

NCT02735707Phase 3Recruiting

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Role: collaborator

NCT03861767Phase 3Terminated

REMAP Trial for Optimizing Surgical Outcomes at UPMC

Role: collaborator

NCT03643939Not ApplicableCompleted

High-Flow Nasal Oxygen Cannula Compared to Non-Invasive Ventilation in Adult Patients With AcuTE Respiratory Failure

Role: collaborator

NCT03260920Phase 2Unknown

Intranasal Oxytocin for Frontotemporal Dementia

Role: collaborator

NCT00734474Phase 2Completed

A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin

Role: collaborator

All 17 trials loaded